1 of 58

Improving Laboratory Efficiency and Cost Effectiveness through Modification of Test Method

Raja Elina Raja Aziddin and Chan Kam Soon

Drug and Research Laboratory, Department of Pathology, Hospital Kuala Lumpur.

OP-11

2 of 58

Selection of Opportunities for Improvement

3 of 58

PROBLEM IDENTIFICATION �& PRIORITISATION

SMART Criteria

PROBLEMS IDENTIFIED

S

M

A

R

T

TOTAL

Limited ATS test throughput

4

5

5

5

4

23

Delay in Laboratory Information System (LIS) report printing

4

4

2

2

2

14

Delay in drug report collection

4

5

4

3

3

19

Sample rejection

2

2

1

3

2

10

Incomplete test request

3

3

2

3

1

12

23

4 of 58

REASONS FOR SELECTION

Criteria

Rationale

Limited ATS test throughput cause delay in ATS test turnaround time which can hamper court proceedings

ATS test throughput can be measured by the number of tests that can be done by the laboratory

Increasing the ATS test throughput will increase laboratory efficiency as the number of ATS test request is the most in number compared to other drug tests

Remedial measure to reduce the ATS specimen processing time and cost is feasible and there are no economical issues which may affect the success of this study.

This study and its remedial measure are manageable with the available resources and can be achieved in a timely manner

MEASURABLE

APPROPRIATE

REMEDIAL

TIMELY

SERIOUSNESS

5 of 58

BACKGROUND

  • Drug & Research Laboratory HKL is the national reference centre for drugs of abuse testing
  • In late 90s we developed a confirmatory method for detection and identification of Amphetamine Type Stimulant (ATS) Drugs

6 of 58

ATS ABUSE

Rising Concern Over Syabu Addiction Among Students In Kedah - Monday, 20 March 2017

NST

No remorse from teenagers nabbed over Keramat tahfiz school fire: Sources

ATS drug abuse - a growing problem in Malaysia

7 of 58

DRUG ABUSE DETECTION

ROLE OF THE LABORATORY

DRUG TEST PROVIDE KEY EVIDENCE

  1. To efficiently reach targeted groups
  2. Prevention
  3. Risk reduction
  4. Warning system
  5. An overview on the actual drug market situation
  6. Clinical management

GIVE INFORMATION TO MAKE THE WORLD BETTER

8 of 58

INTRODUCTION

This increase in ATS abuse trend has resulted in a steady increase of ATS test requests.

Fig 1: Number of ATS samples and test requests received in Hospital Kuala Lumpur showing an increasing trend in the last four years

>65,000 SAMPLES / year

9 of 58

Fig 2: Hospital Kuala Lumpur workload showing the percentage of samples received for different drug tests

ATS

10 of 58

Police

11 of 58

LITERATURE REVIEW

Drug abuse is a global problem that knows no borders. It is a major health problem that impacts communities and take a tremendous toll on the society.

The emergence of new synthetic drugs in recent years has resulted in a change of trend in drug use.

Today traditional illicit substances like heroin are becoming less popular globally, more are turning to new designer drugs such as AMPHETAMINE TYPE STIMULANT (ATS) Drugs.

(World Drug Report: United Nations Office on Drugs and Crime - 2015)

12 of 58

PROBLEM STATEMENT

Monitoring of the ATS drug tests turnaround time showed there is a delay in ATS test result reporting to cater to the existing workload which may hamper court proceedings.

13 of 58

GENERAL OBJECTIVE

To Improve Laboratory Efficiency and Cost Effectiveness through Modification of Test Method

14 of 58

SPECIFIC OBJECTIVES

  1. To validate the modified ATS test method as compared to existing method
  2. To determine the cost of consumables used post modification of ATS method
  3. To implement remedial measures and evaluate its effectiveness

15 of 58

TO IMPROVE

LAB EFFICIENCY

AND

COST EFFECTIVENESS

No new intake

Lab deigned

in early 90s

Limited functioning

fumehood

Maintenance

downtime

30% staff

transfer yearly

Congestion

Manual

Limited trained

personnel

Expensive

Complex

Require

expertise

INADEQUATE WORK AREA

INSUFFICIENT EQUIPMENT

COMPLICATED SAMPLE PROCESSING

INSUFFICIENT MANPOWER

Overworked

instrument

No increase

in GC/MS

Since 2010

16 of 58

OPPORTUNITY FOR CHANGE

January 2015 :

  • Purchased 2 units

Gas

Chromatography

Mass

Spectrometry

(GC/MS) systems

with higher

sensitivity to

replace obsolete

units

17 of 58

Key Measurement for Improvement

18 of 58

MODEL OF GOOD CARE

Sample received

NEGATIVE

POSITIVE

Run Confirmatory Test

Result

analysis

Screening Test

Report

HOSPITALS

Others agencies

14 DAYS

AADK

  • WP
  • Perlis
  • Kedah
  • Melaka
  • Pahang
  • Selangor
  • Perak

19 of 58

Sample Receiving

Sample checking at receiving counter

Preparing of screening

Screening on automated analyser

20 of 58

Specimen processing ( 1 )

Specimen processing ( 2 )

Extraction of sample

Concentration process

( DRYING STEP)

21 of 58

Concentrated sample

( DRYING STEP)

Sample in micro insert tube

( DRYING STEP)

Place into micro vial

Ready for GC/MS analysis

22 of 58

Comfirmatory GC/MS analysis

23 of 58

COMFIRMATORY TEST �WORK PROCESS

Add 20 µL internal standard

Add 0.5 ml buffer

Add 2.5 ml extraction solvent

Add 10 ml derivation reagents

Spin for 3 minutes

Transfer organic phase into drying tubes

Evaporate in dry bath 50ºC to

about 90 µL

Transfer the extract into micro vials with glass insert and cap

Existing ATS test work process

Pipette 2.0 ml urine samples

Ready for GC / MS analysis

Drying steps

24 of 58

COST BENEFIT ANALYSIS

BIL

ITEM

TOTAL COST

1

2

Tank X Month X Cost

8 X 12 Months X RM 250 =

RM 24,000

3

GS / MC filament

Years X Rm 600

= RM 7200

RM 0.95 X 65,000 (samples)

= RM 61,750

25 of 58

INDICATORS AND STANDARD

Standard: turnaround time < than 14 days in 90% of the ATS test requests received.

*Seksyen 117 ( 3 ) KAJ, pihak Majistret mempunyai kuasa bagi membenarkan satu perintah penahan reman dibuat ke atas suspek sehingga 14 hari.

( >14 days eligible as DNAA – Discharge Not Amounting Aquictal).

*KPI of Drug Lab Unit, Pathology Department

The number of ATS samples with less than 14 days test turnaround time

X 100 %

Total number of ATS samples received

26 of 58

Process of Gathering Information

27 of 58

METHODOLOGY

TYPE OF STUDY

Prospective

SAMPLE SIZE

Cases that required ATS confirmatory test

SAMPLING TECHNIQUE

Convenient

LOCATION OF STUDY

Drug and Research Lab HKL

PERIOD OF DATA COLLLECTION

Verification Study

Jun - Aug 2015

Validation Process

Sept – Dec 2015

Implementation of Remedial Measures

Jan 2016 –

Jan 2017

INCLUSION CRITERIA

Samples for ATS confirmatory test

EXCLUSION CRITERIA

Samples not for ATS confirmatory test

Urgent samples

28 of 58

DEFINITIONS

  • ATS test method throughput : Number of samples that can be processed by the laboratory at any specified time
  • ATS test turnaround time: Number of days the laboratory takes to complete testing from the time sample was received by the laboratory to result reporting.
  • Specimen processing time: Time taken to process specimen prior to GC/MS analysis.
  • ATS test: Test that is used to confirm the presence of ATS in the specimen

29 of 58

Analysis And Interpretation

30 of 58

DATA COLLECTION

31 of 58

Strategy for Change

32 of 58

REMEDIAL MEASURES

We established a Modification Of Confirmatory Test Method In Work Process which includes:

  1. Eliminate rate limiting steps which is drying process

  • Reducing sample and chemical volume

  • Change the use of glass inserts to disposable

micro vials

33 of 58

REMEDIAL MEASURES

9

7

34 of 58

REMEDIAL MEASURES

Micro vials with glass insert and cap

Micro vials with barcode

200 ul

1000 ul

35 of 58

Effect of Change

36 of 58

METHOD VALIDATION

Existing method

Modified method

Linearity

0-10,000 mg/ml

Coefficient of variation

r²= 0.9999

0-10,000 mg/ml

Coefficient of variation

r²= 0.9999

Sensitivity

LOD

11-40 ng/mL

20-30 ng/mL

LOQ

33-150 ng/mL

70-90 ng/mL

Accuracy

±20%

±20%

Precision

<10%

<10%

Specificity

No interfering compounds detected at the respective compound retention times

No interfering compounds detected at the respective compound retention times

Stability

1 month

1 month

Table 1: Comparison of method validation data for six ATS analytes

37 of 58

RE-VALIDATION�SIX LEVEL CALIBRATION CURVE - ATS DRUGS

Calibrator Concentrations : 100 ng/ml , 250 ng/ml, 500 ng/ml/ 1000 ng/ml, 2000 ng/ml/ 5000 ng/ml

EQA

CAP

UNODC

38 of 58

METHOD CORRELATION

Fig 4: Scatter plot showing good correlation of Amphetamine results on existing and modified method

Fig 5: Scatter plot showing good correlation of Methamphetamine results on existing and modified method

Method correlation experiments compared the results of 27 samples that were analysed using existing and modified method

39 of 58

PROCESSING TIME

Add 20 µL internal standard

Add 0.5 ml buffer

Add 2.5 ml extraction solvent

Add 10 ml derivation reagents

Spin for 3 minutes

Transfer organic phase into drying tubes

Evaporate in dry bath 50ºC to

about 90 µL

Transfer the extract into micro vials with glass insert and cap

2.5 hrs

Pipette 2.0 ml urine samples

Ready for GC / MS analysis

Drying steps

~ 1 hr

(2.5 – 1)H = 1.5 HRS

40 of 58

ATS TEST THROUGHPUT

Table 2: Comparison of the time taken to process one batch of 78 samples using existing and modified ATS method.

ATS throughput

Increment of Batches

Existing method

Modified method

Number of batches and samples processed per day

3 batches

(234 samples)

6 batches

(468 samples)

50%

41 of 58

ATS TEST THROUGHPUT

The modified method reduced sample processing time by 50%, resulting in a doubling of ATS test throughput per day.

Fig 6: Comparison of number of samples processed per day with existing and modified method

50%

42 of 58

TURNAROUND TIME

Fig 7: Percentages of ATS specimens with turnaround time of less than 14 days

43 of 58

COST COMPARISON

Table 3: Cost savings calculated based on the consumables used for the total ATS workload in 2016

44 of 58

COST COMPARISON

Cost saving of 46.6% which amounted to RM46,350 per year.

Fig 8: Cost reduction post modification of test method.

RM 46,350 / YEAR

45 of 58

ABNA

Number of ATS specimens with turnaround time of less than 14 days

46 of 58

Lesson Learnt �And �The Next Step

47 of 58

LESSONS LEARNT

  1. HKL pioneered this modified ATS test method

  • The performance of modified ATS test results is comparable to existing method

48 of 58

LESSONS LEARNT

3) Simple modifications has resulted in saving of :

a) Time

b) Cost

c) Reducing errors :

- by using micro vial with barcode

d) Human Resources :

- physical activity such as tube transfers,

washing of micro vials, frequency of

changing gas tanks and instrument

filament.

49 of 58

THE NEXT STEP

Phase 1

1) Information on the use of new modified ATS test method was announced during National Pathology Meeting

UPDATES ON DRUG ABUSE TESTING SERVICE IN HKL�Mesyuarat Perkhidmatan Patologi KKM

Bil. 2/2017 - 14 Ogos 2017

50 of 58

51 of 58

THE NEXT STEP

Phase 1

2) Conduct training / seminar to other ATS testing centres on the use of the modified method

52 of 58

STAFF TRAINING

53 of 58

SEMINAR

54 of 58

THE NEXT STEP

Phase 1

3) Short attachment in HKL on the use of the modified ATS test method in HKL for representative from other centres

55 of 58

Letter : Request of Attachment

56 of 58

THE NEXT STEP

Phase 2

  1. Additional of 4 NEW SYNTHETIC DRUGS into the ATS panel
  2. Implement modified method in all 7 OTHER REGIONAL ATS TESTING CENTER
  3. Based on cost saving of RM 46,350/annum we were able to develop a NEW SERVICE for the detection of 46 NEW DRUGS using Tandem Mass Spectomectry (TMS)

57 of 58

HKL pioneered the existing and current modified ATS test method.

Continuous quality improvement activities is important to ensure excellent service provision.

CONCLUSION

58 of 58